Public COA audit

GHK-Cu · Thymosin Beta-4

Audited September 5, 2026

Mostly consistent, with concerns

Several fields check out, but we found issues worth reviewing before you rely on this document.

Legitimacy
72
Confidence
85%
Panels
4/7
Purity (printed)
99.68%

Scored moderately because the document is mostly consistent but carries soft concerns, limited panel coverage (4/7), 3 soft concerns, and notable note: "High purity confirmed". To improve: include identity, purity, and endotoxin at minimum.

Document details

Fields extracted from the certificate — not order or payment data.

Batch / lot
GLOW-062026-4
Identity method
LC-MS
Sample date
2026-06-03
Issue date
2026-06-07

Original certificate

Embedded copy of the stored COA PDF or image. Download it for your records — PeptIQ’s audit is separate from the lab document itself.

Loading original certificate…

7-panel checklist

Had data + good, had data + bad, reported without pass/fail, or missing. Missing lowers thoroughness — you decide whether that panel matters; PeptIQ’s score still factors coverage.

4 of 7 present · 4 passed · 0 failed · 0 reported · 3 missing

Missing is a thoroughness gap — not automatically bad. PeptIQ’s legitimacy score still weighs panel coverage; you can down-weight panels that don’t matter for your use case.

  • Identity

    Tested · passed · core

    Compound identity confirmed (e.g. HPLC, mass spec).

    GHK-Cu/Thymosin Beta-4/BPC-157

  • Purity

    Tested · passed · core

    Reported purity percentage for the analyte.

    99.68%

  • Heavy metals

    Not on this certificate file

    Lead, arsenic, cadmium, mercury, or similar limits.

    No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”

  • Microbial

    Tested · passed

    Bioburden / microbial limits testing.

    No Detectable Microbial DNA

  • Endotoxin

    Tested · passed · core

    LAL or chromogenic endotoxin assay.

    Replicate 1: Pass, Replicate 2: Pass

  • Sterility

    Not on this certificate file

    Sterility testing where applicable.

    No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”

  • Residual solvent / water

    Not on this certificate file

    Residual solvents or water content limits.

    No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”

How to read this

Had data · good

Panel present with a pass (or clear acceptance).

Had data · bad

Panel present with a fail — a concrete quality signal.

Had data · unclear

Value reported without an explicit pass/fail mark.

Missing on this file

Not on this certificate file. Lowers file thoroughness; a sibling endotoxin/purity report for the same lot may still exist. PeptIQ’s score still factors coverage.

Findings

Evidence-linked observations from this audit.

  • High purity confirmed

    Average purity of 99.68% across two vials (99.60% and 99.75%) is consistent with quality research-grade peptides

  • Identity confirmed by LC-MS

    All three peptides (GHK-Cu, Thymosin Beta-4, BPC-157) confirmed with mass spectrometry data shown

  • Endotoxin testing performed

    LAL assay per USP <85> with two replicates both passing, sensitivity ≤0.05 EU/mL

  • Microbial testing performed

    PCR-based assay detected no microbial DNA

  • Lab verification unclear

    Freedom Diagnostics Testing website and contact information provided, but independent verification of lab accreditation/credentials not possible from document alone

  • Blend product complexity

    Three-peptide blend with individual quantification shown for each component across two vials; net content values show reasonable variation between vials

  • Missing heavy metals and residual solvent panels

    No heavy metals or residual solvent/water content testing shown; these are common but not universal panels for research peptides

  • Dates are valid

    Received 2026-06-03, Reported 2026-06-07 (4-day turnaround); both dates are on or before current date 2026-09-05

PeptIQ COA reports analyze document content and publicly verifiable lab signals. They are educational and not a guarantee of product quality, legality, or safety. Always consult a qualified professional before making health decisions. We never publish purchase prices, shipping details, or uploader identity.